Study on Nipple-Sparing Mastectomy for Women with BRCA Mutations
Background on Breast Cancer Risks
Researchers have investigated the safety of nipple-sparing mastectomy as a preventive surgical procedure for breast cancer in women carrying BRCA gene mutations. While various factors contribute to breast cancer risk, a significant one is a family history of the disease. Specific mutations in breast cancer suppressor genes, known as BRCA, have been identified in several families affected by multiple breast cancer cases. These genes are crucial in regulating cell division in breast tissue, and abnormal BRCA genes significantly elevate the risk of developing breast cancer.
Understanding BRCA Mutations
Women with BRCA mutations face approximately a 50% lifetime risk of developing breast cancer, in stark contrast to the roughly 12% risk for women in the general U.S. population. Due to this heightened risk, some women may opt for mastectomy as a preventive measure against breast cancer.
Types of Mastectomy
Mastectomies vary in the amount of breast tissue removed, with nipple-sparing mastectomy preserving the nipple and surrounding skin. This approach is increasingly popular due to its favorable cosmetic outcomes, although it may not be suitable for every patient.
Research Findings from the Mayo Clinic
Researchers at the Mayo Clinic conducted a study to determine the safety of nipple-sparing mastectomy for women with BRCA mutations. Their findings were published in JAMA Surgery. The study encompassed data from nine institutions that performed nipple-sparing mastectomies from 1968 to 2013 on women with BRCA mutations. A total of 548 procedures were analyzed, involving 346 patients—some underwent surgery on both breasts while others had it on one breast following cancer treatment on the other side.
Patient Follow-Up and Results
Patients were monitored for an average of 34 months, during which no instances of breast cancer were reported. Despite the relatively short follow-up period, the researchers concluded that nipple-sparing mastectomies are a safe and effective preventive option for women with BRCA mutations. They recommend offering this procedure to suitable patients to mitigate their breast cancer risk.
Conclusion
This study highlights the potential of nipple-sparing mastectomy as a viable preventive strategy for women at high risk of breast cancer due to BRCA mutations.
Reference
Jakub J, Warren Peled A, Gray RJ, et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations. A multi-institutional study. JAMA Surgery Published online September 13, 2017. Doi: 10.1001/jamasurg.2017.3422.